1.New advances of adiponectin in regulating obesity and related metabolic syndromes
Han YANQI ; Sun QIANWEN ; Chen WEI ; Gao YUE ; Ye JUN ; Chen YANMIN ; Wang TINGTING ; Gao LILI ; Liu YULING ; Yang YANFANG
Journal of Pharmaceutical Analysis 2024;14(5):623-638
Obesity and related metabolic syndromes have been recognized as important disease risks,in which the role of adipokines cannot be ignored.Adiponectin(ADP)is one of the key adipokines with various beneficial effects,including improving glucose and lipid metabolism,enhancing insulin sensitivity,reducing oxidative stress and inflammation,promoting ceramides degradation,and stimulating adipose tissue vascularity.Based on those,it can serve as a positive regulator in many metabolic syndromes,such as type 2 diabetes(T2D),cardiovascular diseases,non-alcoholic fatty liver disease(NAFLD),sarcopenia,neurodegenerative diseases,and certain cancers.Therefore,a promising therapeutic approach for treating various metabolic diseases may involve elevating ADP levels or activating ADP receptors.The modulation of ADP genes,multimerization,and secretion covers the main processes of ADP generation,providing a comprehensive orientation for the development of more appropriate therapeutic strategies.In order to have a deeper understanding of ADP,this paper will provide an all-encompassing review of ADP.
2.Drug accumulation and coma caused by the combination of donepezil and memantine
Adverse Drug Reactions Journal 2024;26(3):188-190
An 87-year-old female patient with Alzheimer's disease received donepezil 5 mg once daily orally for 8 years and then memantine 10 mg once daily orally was added due to the progression of the condition. Three months later, the patient suddenly fell into a coma and did not respond to call, acompanied by shortness of breath and wheezing. The patient had needle like changes in the pupils of both eyes, with blood pressure 190/100 mmHg and heart rate 56 beats per minute. The Glasgow Coma Scale (GCS) was E1V1M1. It was considered that the patient was poisoned due to drug accumulation caused by combination use of donepezil and memantine (blood concentration of methotrexate 215 mg/L, warning value: 30 mg/L; blood concentration of donepezil 33 mg/L, warning value: 20 mg/L). The 2 drugs were stopped, and symptomatic and supportive treatments such as fluid hydration, blood pressure reduction, and brain awakening were given. On the 3th day after drug discontinuation, the patient′s consciousness temporarily shifted to drowsiness, and her GCS was E1V1M1; on the 7th day after drug discontinuation, the patient′s consciousness became clear and she was able to answer simple questions, with GCS E4V4M4, blood pressure 126/67 mmHg, and normal pupil size.
3.Drug accumulation and coma caused by the combination of donepezil and memantine
Adverse Drug Reactions Journal 2024;26(3):188-190
An 87-year-old female patient with Alzheimer's disease received donepezil 5 mg once daily orally for 8 years and then memantine 10 mg once daily orally was added due to the progression of the condition. Three months later, the patient suddenly fell into a coma and did not respond to call, acompanied by shortness of breath and wheezing. The patient had needle like changes in the pupils of both eyes, with blood pressure 190/100 mmHg and heart rate 56 beats per minute. The Glasgow Coma Scale (GCS) was E1V1M1. It was considered that the patient was poisoned due to drug accumulation caused by combination use of donepezil and memantine (blood concentration of methotrexate 215 mg/L, warning value: 30 mg/L; blood concentration of donepezil 33 mg/L, warning value: 20 mg/L). The 2 drugs were stopped, and symptomatic and supportive treatments such as fluid hydration, blood pressure reduction, and brain awakening were given. On the 3th day after drug discontinuation, the patient′s consciousness temporarily shifted to drowsiness, and her GCS was E1V1M1; on the 7th day after drug discontinuation, the patient′s consciousness became clear and she was able to answer simple questions, with GCS E4V4M4, blood pressure 126/67 mmHg, and normal pupil size.
4.A multi-center survey on the application of antibacterial agents in Chinese children in 2019
Jiaosheng ZHANG ; Xiang MA ; Lanfang TANG ; Daiyin TIAN ; Li LIN ; Yanqi LI ; Jing QIAN ; Wenshuang ZHANG ; Wei LI ; Gen LU ; Ligang SI ; Ping JIN ; Liang ZHU ; Keye WU ; Jikui DENG ; Yuejie ZHENG ; Yonghong YANG
Chinese Journal of Applied Clinical Pediatrics 2022;37(14):1074-1081
Objective:To analyze the patterns of antibacterial agents in Chinese children surveyed by the China multi-center monitoring network for the application of antibacterial agents in children and neonates in 2019 by using World Health Organization (WHO) Access, Watch, Reserve and Not-recommended (AWaRe) and typical anatomical/therapeutic/chemical (ATC) in this study.Methods:The cross-sectional method was adopted.A multi-center cross-sectional survey was conducted on one day from September to December 2019.The information of all inpatients taking antibiotics was uploaded to the network-based data collection system (https: //garpec-31.mobilemd.cn/login.aspx? relogin=true). This study covered 13 hospitals from 10 provinces and cities in China.All hospitalized children in the Respiratory Department, Infectious Disease Department, General Surgery Department, Pediatric Intensive Care Units, Neonatal Intensive Care Units and Neonatology joined in this survey.The clinically used antibacterial agents were classified by AWaRe and ATC, and the AWaRe and ATC distributions of antibacterial agents prescribed for Chinese children and neonates were described.Results:Of the 2 644 antibiotic prescriptions included from 13 hospitals, 2 134 (80.71%) were for children and 510 (19.29%) were for neonates.Of all antibiotic prescriptions, there were 368 (13.92%) Access antibiotics prescriptions, 1 973 (74.62%) Watch prescriptions, 60 (2.27%) Reserve prescriptions and 243 (9.19%) Not-recommended prescriptions.The top-five antibiotics prescribed for children and neonates were third-generation cephalosporins (1 056, 39.94%), macrolides (492, 18.61%), carbapenems (275, 10.40%), beta lactam-beta lactamase inhibitors (246, 9.30%), and second-generation cephalosporins (136, 5.14%). The use ratios of Access, Watch, Reserve and Not-recommended antibiotics in each center ranged from 0 to 30.00%, 36.67% to 97.20%, 0 to 17.02% and 0 to 33.33%, respectively.In 1 360 antibiotic prescriptions for children and neonates with pneumonia, there were 152 (11.18%) Access antibiotics, 1 051 (77.28%) Watch antibiotics, 37 (2.72%) Reserve antibiotics, and 120 (8.82%) Not-recommended antibiotics.The top-five antibiotics prescribed for children with pneumonia were third-generation cephalosporins (522, 38.38%), macrolides (388, 28.53%), beta lactam-beta lactamase inhibitors (141, 10.37%), carbapenems (117, 8.6%) and penicillins (49, 3.60%).Conclusions:Watch antibiotics and broad spectrum antibiotics such as third-generation cephalosporins and macrolides prone to induce resistance are the main antibacterial agents used in Chinese children and neonates with pneumonia.Broad-spectrum antibiotics may be overused in Chinese children and neonates.
5.Working Mode and Case Analysis of the First Pharmaceutical Ward Rounds in Our Hospital
Wei ZHUANG ; Suying YAN ; Xiaolan LIN ; Fei CHEN ; Li GAO ; Yingnan FENG ; Jing TANG ; Beibei JIA ; Yanqi CHU
China Pharmacy 2021;32(17):2129-2133
OBJECTIVE:To est ablish the working mode of the first pharmaceutical ward rounds of clinical pharmacists in our hospital,in order to provide a useful reference for establishing a national standardized pharmaceutical ward rounds model. METHODS:By sharing the clinical cases of the first pharmaceutical ward rounds ,the work content and process of the first pharmaceutical ward rounds in our hospital were introduced. RESULTS & CONCLUSIONS :The clinical pharmacist ’s first pharmaceutical ward round in our hospital mainly includes self introduction of clinical pharmacists ,diagnosis of patients ’condition under the guidance of doctors ,collection and evaluation of patients ’previous medication information (including previous medication varieties ,usage methods ,efficacy and safety evaluation ),assistance for doctors in formulating initial treatment plan , carrying out initial medication and diet education ,and intensive communication and cooperation with nurses. The development of first pharmaceutical ward rounds promotes the rational use of drugs in clinic ,elevates the hospitalization satisfaction of patients and improves the professional quality of clinical pharmacists.
6.Etiology and epidemiology of chronic cough aged 6-14 years in children
Xiuya ZHANG ; Mingyue XIA ; Ling LIU ; Yanqi LIU ; Wei HUANG
Journal of Public Health and Preventive Medicine 2021;32(2):89-91
Objective To investigate the incidence and risk factors of chronic cough in children aged 6-14 years. Methods The incidence of chronic cough in children aged 6-14 years in Qinhuangdao city was investigated by questionnaire. Results A total of 4 000 questionnaires were distributed, 3 785 of them were effectively recovered, with the recovery rate of 94.6%. The incidence of chronic cough in children aged 6-14 was 5.1% (194/3 785). The prevalence rates of boys and girls were 5.4% (101/1 859) and 4.8% (93/1 926), respectively, with no significant difference (χ2=0.641,P=0.873). The incidence rate of children in industrial town area 6.7% (64/955) was significantly higher than that in urban area 4.4% (85/1 917) and agricultural town 4.9% (45/913) (χ2=55.082,P=0.000). The risk factors showed that chronic cough was associated with long-term allergen exposure, allergic constitution, asthma, rhinitis, reflux esophagitis and other nasopharynx diseases (χ2=17.833,43.370,194.466,27.773,101.92,11.268,P =0.000). Regression model analysis showed that asthma, rhinitis and allergen long-term exposure were independent risk factors of chronic cough (Wald=15.352,10.174,12.625,12.659,P =0.000). Conclusion The incidence rate of children in industrial town is higher in Qinhuangdao City than those in other urban areas, 6~14 years old children. Asthma, rhinitis and allergen exposure are the main causes of chronic cough.
8. Successful treatment for the first confirmed noval coronavirus-infected pneumonia in Guizhou Province
Yanqi WU ; Daixiu GAO ; Feng SHEN ; Lulu XIE ; Shuangzi LIZHANG ; Yue WU ; Guimei LI ; Liang LI ; Wei LI ; Bo LIU
Chinese Critical Care Medicine 2020;32(2):E008-E008
Noval coronavirus-infected pneumonia is an acute respiratory infectious diease caused by an noval coronavirus, and it is highly contagious. The first confirmed coronavirus-infected pneumonia in Guizhou was admitted to the department of Critical Care Medicine, Affiliated Hospital of Guizhou Medical University. After has been given isolation, anti-viral therapy, oxygen therapy, maintaining internal environment stability, organ functions protection and psychological comfort for 8 days, the patient successfully recovered from the disease. It is suggested that early recognition, early isolation, timely antiviral treatment, organ function protection and psychological intervention are effective methods for patient with noval coronavirus-infected pneumonia.
9.Effect of linguistic strategies in traditional Chinese medicine English teaching courses for foreign students
Mingyue LI ; Bo CHEN ; Yanqi LI ; Shufei FU ; Wei WANG
International Journal of Traditional Chinese Medicine 2019;41(5):537-540
It's important that the university teachers apply proper linguistic strategies in the Traditional Chinese medicine courses for foreign students,which can reduce the non-native language ability limitation to teaching effect to a certain extent,which can let students better understand and grasp the contents.This paper summarize the influence of linguistic strategies on teaching effect,such as signposting,signalling importance,back channeling,repetition,questioning,commenting,which is the important foundation and powerful guarantee of ideal teaching effects of EMI.
10.Performance of clinical pulmonary infection score induces the duration and defined daily doses of antibiotics in patients with bacterial severe pneumonia in intensive care unit
Feng SHEN ; Yanqi WU ; Yahui WANG ; Wei LI ; Bo LIU ; Hong QIAN ; Huilin YANG ; Guixia YANG ; Xiang LI ; Xinghao ZHENG ; Yu WU ; Lulu XIE ; Daixiu GAO ; Liang LI ; Min LIU
Chinese Critical Care Medicine 2019;31(5):556-561
Objective To explore the impacts of clinical pulmonary infection score (CPIS) on duration and defined daily doses (DDDs) of antibiotics in patients with bacterial severe pneumonia in intensive care unit (ICU). Methods Patients with severe pneumonia, whose antibiotic usage was prescribed with the guide of CPIS, and admitted to ICU severe respiratory and infectious disease ward of Guizhou Medical University Affiliated Hospital from May 2017 to October 2017 were enrolled as CPIS group. Patients with the first CPIS score > 5 were given antimicrobial therapy, and the score was dynamically evaluated every 2-3 days. If the CPIS score < 5, the score was evaluated again after 2 days. If the score was still < 5, the antimicrobial drugs were discontinued. Patients admitted to the same ward from November 2016 to April 2017 were regarded as controls, of whom the antibiotic usage was completely conducted by the clinical experience of the chief physician. The duration and DDDs of antibiotics were compared between patients in two groups. At the same time, the usage of ventilator and prognostic indicators (the length of ICU stay, ICU mortality) were recorded. Kaplan-Meier survival curve was drawn, and the cumulative survival rates of 28 days, 90 days and 12 months were analyzed and compared between the two groups. Results In our department, 177 and 182 patients were admitted to ICU from November 2016 to April 2017 and from May 2017 to October 2017, respectively, of whom 101 and 65 patients with severe pneumonia were collected respectively during the two stages. There was no significant difference in gender composition, age, underlying diseases, vital signs, acute physiology and chronic health evaluation Ⅱ (APACHEⅡ) score, or peripheral blood routine at admission between the two groups, indicating that the baseline data of the two groups were equally comparable. During the treatment process, there was no significant difference in the duration of mechanical ventilation [hours: 126.0 (69.0, 228.8) vs. 120.0 (72.0, 192.0)], the length of ICU stay [days: 7.0 (5.0, 11.0) vs. 8.0 (5.0, 14.0)], or ICU mortality [18.8% (19/101) vs. 26.2% (17/65)] between the control group and CPIS group (all P >0.05). Kaplan-Meier survival curve analysis showed that there was no significant difference in the cumulative survival rate of 28 days (log-rank test: χ2 = 0.540, P = 0.462), 90 days (log-rank test: χ2 = 0.332, P = 0.564) or 12 months (log-rank test: χ2 = 0.833, P = 0.362). Patients from CPIS guided group, however, had a shorter duration of antibiotics usage (days: 7.54±4.81 vs. 9.88±4.96, P < 0.01), and had a lower DDDs of antibiotics (17.58±13.09 vs. 22.73±18.31, P < 0.05) as compared with those in the control group. Conclusion CPIS-guided therapeutic regimen shortens antibiotic duration and decreases antibiotic DDDs in patients with severe pneumonia in ICU, indicating the values of CPIS in guiding antibiotics usage in these patients.


Result Analysis
Print
Save
E-mail